Zacks.com on MSN13h
Pharma Stock Roundup: EU Nod to MRK's Welireg, IONS' Q4 Results & MoreThis week, the European Commission granted approval to Merck’s MRK novel HIF-2α inhibitor, Welireg, for two indications. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback